Vendor-specific microbiome controls both acute and chronic murine lung allograft rejection by altering CD4+Foxp3+ regulatory T cell levels
Yizhan Guo(Carter Center), Alexander Sasha Krupnick(Carter Center), Zhongcheng Mei(Carter Center), Qing Wang(Carter Center), Oscar Okwudiri Onyema(University of Virginia), David S. Wilkes(Indiana University School of Medicine), Anirban Banerjee(University of Maryland, Baltimore), Dongge Li(Carter Center), Daniel Kreisel(Washington University in St. Louis), Mark H. Stoler(University of Virginia), Thomas H. Barker(University of Virginia), Amir Manafi(Arrowhead Regional Medical Center), Andrew E. Gelman(University of Washington), Bayan Mahgoub(University of Virginia)
Cited by 37
Related Papers
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
|Archives of Pathology & Laboratory Medicine|2012|999
Tissue Resident CCR2− and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury
|Circulation Research|2019|717
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Maleimide Cross‐Linked Bioactive PEG Hydrogel Exhibits Improved Reaction Kinetics and Cross‐Linking for Cell Encapsulation and In Situ Delivery
|Advanced Materials|2011|543
Matrix Stiffness–Induced Myofibroblast Differentiation Is Mediated by Intrinsic Mechanotransduction
|American Journal of Respiratory Cell and Molecular Biology|2012|527